Table 4:

Rates of Therapy Initiation, Continuation, and Recommendations

Outcome	Physician-Managed	Pharmacist-Managed	p-value
Primary Outcome
Rate of initiation or continuationa in high-risk patientsb, nc (%)	85d (35.8)	206e (66.2)	< 0.001
Secondary outcomes
Rate of prescription antifracture therapy recommendationf in high-risk patientsb, nc (%)	76 (32.1)	271 (87.1)	< 0.001
Calcium and vitamin D recommendationf in all patientsf, nc (%)	253 (46.1)	446 (95.7)	< 0.001
Calcium and vitamin D recommendationf in low- to moderate-risk patientsh, nc (%)	142 (45.5)	151 (97.4)	< 0.001

^aInitiation and continuation rates were determined by reviewing prescription authorization history, as detailed in Methods.

^bHigh risk patient groups: physician-managed (n = 237 DXA scans in 174 unique patients) vs. pharmacist-managed (n = 311 DXA scans in 221 unique patients)

^cNumber of DXA scans

^dInitiation in 27 patients and continuation in 58 patients in physician-managed group

^eInitiation in 119 patients and continuation in 87 patients in pharmacist-managed group

^fRecommendations were determined from reviewing all documented chart notes, letters, physician-to-patient emails, telephone calls, office visits, and hospital admissions within the month following DXA scan.

^gAll patient groups: physician-managed (n = 549 DXA scans) vs. pharmacist-managed (n = 466 DXA scans)

^hLow-to-moderate risk patient groups: physician-managed (n = 312 DXA Scans) vs. pharmacist-managed (n = 155 DXA scans)